Abstract
The effects of several membrane-acting drugs on malaria and sickle cell anemia was studied. In the initial experiments, propranolol and W-7 were shown to increase red cell density.In vitro, these drugs inhibited the growth ofP. falciparum. However,in vivo experiments using the murine malarial parasite,P. vinckei, demonstrated little, if any, anti-parasite activity with the doses of drugs employed. Subsequently, prostaglandin oligomeric derivatives were found to inhibit the growth ofP. falciparum in vitro andP. vinckei in vivo. Since prostaglandin oligomers inhibited the formation of dense, dehydrated cells (irreversible sickle cells), they may also have therapeutic efficacy in sickle cell anemia.
Article PDF
Similar content being viewed by others
References
Peters W: Antimalarial drug resistance: an increasing problem. British Medical Bulletin 38: 187–192, 1982
Friedman MJ: Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci (USA) 75: 1994–1997, 1978
Friedman M, Roth EF, Nagel RL, Trager W: The role of hemoglobins C, S, and NBaly in the inhibition of malaria parasite development in vitro. J Trop Med Hyg 28: 777–780, 1979
Eaton JW, Skelton TD, Swofford HS, Kolpin CE, Jacob HS: Elevated erythrocyte calcium in sickle cell disease. Nature 246: 105–106, 1973
Palek J: Calcium accumulation during sickling of hemoglobin S (HbSS) red cells. Blood 42: 988, 1973
Palek J, Thomae D, Ozog D: Red cell calcium content and transmembrane calcium movements in sickle cell anemia. J Lab Clin Med 89: 1365–1374, 1977
Lew VL, Hockaday A, Sepulveda, MI, Somlyo AP, Somlyo AV, Ortiz OE, Bookchin RM: Compartmentalization of sickle cell calcium in endocytic inside-out vesicles. Nature 315: 586–589, 1985
Ohnishi ST: The role of calmodulin in sickle cell anemia.In ‘Calmodulin Antagonists and Cellular Physiology’ (Hidaka H, Hartshorne DJ, eds.) pp. 161–183, Academic Press, N.Y., 1985
Ohnishi ST, Horiuchi KY, Horiuchi K: Nitrendipine, nifedipine and verapamil inhibit thein vitro formation of irreversibly sickled cells. Pharmacology 32: 248–256, 1986
Ohnishi ST, Horiuchi KY, Horiuchi K: The mechanism ofin vitro formation of irreversibly sickled cells and modes of action of its inhibitors. Biochim Biophys Acta 886: 119–129, 1986
Ohnishi ST: Why do sickle cells sickle into a sickle shape? in ‘Approaches to the Therapy of Sickle Cell Anemia’, (Beuzard Y, Charache S, Galacteros F, eds.) Les Editions INSERM, Colloque Vol. 141, pp 337–354 (1986) Creteil, France.
Friedman MJ, Proc Natl Acad Sci USA 75, 1994–1997, 1978
Ohnishi ST, Katsuoka M, Hidaka S: A prostaglandin oligomeric derivative inhibits activities of phospholipase and protease: A possible mechanism of membrane protection during ischemia. Cell Biochem Function 7: 51–55, 1989
Jensen JB, Trager W: Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle jar method. J Parasitology 63: 883–836, 1977
Grun JL, Weidanz BP: Cultivation of plasmodium falciparum in commercially available sera depleted of natural antibodies reactive with human erythrocytes. J Parasit 73: 384–388, 1987
Ohnishi ST: Inhibition of thein vitro formation of irreversibly sickled cells by cepharanthine. British J. of Haematology 55: 665–671, 1983
Manninen V: Movements of sodium and potassium ions and their traces in propranolol-treated red cells and diaphragm muscle. Acta Physiol Scand Suppl 355: 1–76, 1970
Tanabe K, Mikkelsen RB, Wallach DF: Calcium transport of plasmodium chabaudi-infected erythrocytes. J Cell Biol 93: 680–684, 1982
Wasserman M, Alarcon C, Mendoza PM: Effects of Ca++ depletion on the asexual cell cycle of plasmodium falciparum. Am J Trop Med Hyg 31: 711–717, 1982
Dunn MJ: Alterations of red blood cell sodium transport during malarial infection. J Clin Invest 48: 674–684, 1969
Mikkelsen RB, Tanabe K, Wallach D: Membrane potential of plasmodium-infected erythrocytes. J Cell Biol 93: 685–689, 1982
Krungkrai J, Yuthavong Y: Enhanced Ca2+ uptake by mouse erythrocytes in malarial (plasmodium Berghei) infection. Molecul Biochem Parasitol 7: 227–235, 1983
Scheibel LW, Colombani PM, Hess AD, Aikawa M, Atkinson CT, Milhous WK: Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): Implication for drug design. Proc Natl Acad Sci USA 84: 7310–7314, 1987
Method of preventing the growth of malaria parasites in erythrocytes. United States Patent No. 4,681,899, 1987
Ohnishi ST, Ohnishi N, Oda Y, Katsuoka M: Prostaglandin derivatives inhibit the growth of malarial parasite in mice. Cell Biochem Function 7: 105–109, 1989
Pasvol G, Wilson RJM: The interaction of malaria parasites with red blood cells. British Medical Bulletin 38: 133–140, 1982
Kometani T, Devlin TM, Ohnishi ST: Studies of the cation binding properties of an oligomeric derivative of prostaglandin B1. Prostaglandins, Leukotrienes and Essential Fatty Acids 317: 37–43, 1989
Ohnishi ST, Teiji Tominaga, Katsuoka M: Inhibition of ischemic brain edema formation by post-ischemic administration of a prostaglandin oligomer. Prostagland leuko essent fat acids 37: 107–111, 1989
Ohnishi ST, Katsuoka M: Protection of the heart from ischemia by a new oligomeric derivative of prostaglandin E1. Prostagland Leuko Essent Fat Acids 36: 159–163, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohnishi, S.T., Sadanaga, K.K., Katsuoka, M. et al. Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes. Mol Cell Biochem 91, 159–165 (1989). https://doi.org/10.1007/BF00228091
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00228091